GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Total Tax Payable

IMGT (XKRX:456570) Total Tax Payable : ₩0.00 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is IMGT Total Tax Payable?

IMGT's Total Tax Payable for the quarter that ended in Dec. 2023 was ₩0.00 Mil.

IMGT Total Tax Payable Historical Data

The historical data trend for IMGT's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT Total Tax Payable Chart

IMGT Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Tax Payable
- - - -

IMGT Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Total Tax Payable - - - -

IMGT Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

IMGT Total Tax Payable Related Terms

Thank you for viewing the detailed overview of IMGT's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

IMGT (XKRX:456570) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Total Tax Payable
Comparable Companies
XKRX:036480 XKRX:208340 XKRX:115180 XKRX:344860 XKRX:383930 XKRX:298060 XKRX:065650 XKRX:299660 XKRX:179530 XKRX:142760 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605
Website
http://www.imgt.co.kr
IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT (XKRX:456570) Headlines

No Headlines